Back
Matinas BioPharma Holdings 10K Form
Sell
38
MTNB
Matinas BioPharma Holdings
Last Price:
0.58
Seasonality Move:
5.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MTNB News And Ratings
See the #1 stock for the next 7 days that we like better than MTNB
MTNB Financial Statistics
Sales & Book Value
| Annual Sales: | $1.1M |
|---|---|
| Cash Flow: | $-3.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.10 |
| Price / Book: | 0.2 |
Profitability
| EPS (TTM): | -4.79000 |
|---|---|
| Net Income (TTM): | $-21.13M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Matinas BioPharma Holdings Earnings Forecast
Key Matinas BioPharma Holdings Financial Ratios
- The Research & Development expenses have been 1,321.99% of Revenue.
- The Net Earning history of MTNB is -2,093.25% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 5 years.
Matinas BioPharma Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MTNB |
| Website: | matinasbiopharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MTNB Technical Analysis vs Fundamental Analysis
Sell
38
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy or a Sell?
-
Matinas BioPharma Holdings stock is rated a Sell
The current Matinas BioPharma Holdings [MTNB] share price is $0.54. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.